Breast Cancer Screening for Women Aged 40–49 Years: Screening May Not Be the Benign Process Usually Thought

• Published in: JNCI : Journal of the National Cancer Institute Vol. 93; no. 20; p. 1572
• Main Authors: Retsky, Michael, Demicheli, Romano, Hrushesky, William
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 17.10.2001; Oxford Publishing Limited (England)
• Subjects: Adult; Biopsy; Breast Neoplasms - diagnosis; Breast Neoplasms - mortality; Breast Neoplasms - pathology; Breast Neoplasms - surgery; Canada; Consensus Development Conferences, NIH as Topic; Disease Progression; Endothelial Growth Factors - blood; Female; Growth Substances - metabolism; Humans; Lymphatic Metastasis; Lymphokines - blood; Mammography; Mass Screening - adverse effects; Mastectomy - adverse effects; Menstrual Cycle; Middle Aged; Models, Biological; Neovascularization, Pathologic - etiology; Premenopause; Progesterone - blood; Randomized Controlled Trials as Topic; United States; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors
• ISSN: 0027-8874; 1460-2105
• DOI: 10.1093/jnci/93.20.1572

when progesterone concentration is elevated (6).MICHAEL RETSKYROMANO DEMICHELIWILLIAM HRUSHESKYREFERENCES(1) Fletcher SW. Whither scientific deliberationin health policy recommendations? Alice inthe Wonderland of breast-cancer screening. NEngl J Med 1997;336:11803.(2) Retsky M, Demicheli R, Hrushesky W. Premenopausal status accelerates relapse in nodepositive breast cancer: hypothesis links angiogenesis, screening controversy. Breast CancerRes Treat 2001;65:21724.(3) Retsky M, Demicheli R, Hrushesky W.